'Quick, Affordable' Test Helps Predict CGRP Response for Migraine
Testing for nonictal cephalic allodynia can help determine with high accuracy which migraine patients will (and which will not) respond to treatment with the anti-CGRP agent galcanezumab.
Medscape Medical News
source https://www.medscape.com/viewarticle/988530?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/988530?src=rss
Comments
Post a Comment